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Although the normal glomerulus comprises four resident cell
types, least is known about the parietal epithelial cells (PECs).
This comprehensive review addresses the cellular origin of
PECs, discusses the normal structure and protein makeup of
PECs, describes PEC function, and defines the responses to
injury in disease and how these events lead to clinical events.
The data show that PECs have unique properties and that
new functions are being recognized such as their role in
differentiating into podocytes during disease.
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Diabetic and non-diabetic glomerular diseases remain the
leading causes of chronic and end-stage kidney disease. The
glomerulus is a complicated structure comprising two major
compartments, the glomerular tuft and the extra-glomerular
tuft (Figure 1). Further complexity is underscored by the
fact that the glomerulus comprises four resident cell types.
Mesangial cells, endothelial cells, and podocytes are within
the glomerular tuft, whereas parietal epithelial cells (PECs)
comprise the extra-glomerular tuft. These observations beg
four major questions. First, from a clinical standpoint, are
there diseases specific to each glomerular cell type? Studies
have indeed shown that primary injury to each of these cell
types is associated with a specific disease. Second, what are
the specific functions of each glomerular cell type, and what
unique genes make this possible? There is an increasing
literature defining the molecular anatomy and biological
functions of mesangial cells, endothelial cells, and podocytes.
However, comparatively little is known about PECs. Third,
how does each cell type respond to injury? Again, although
much is known about the cells in the tuft, very little is
understood about the PECs, except that they proliferate
under certain circumstances. Finally, do the four glomerular
cells communicate with one another, and if so, how does
this ‘cross-talk’ happen? The overall literature is sparse in
this field.
Given that major research and clinical strides have been
made with mesangial cells, glomerular endothelial cells, and
podocytes in the past decade, the PECs are now the ‘poorly
understood family member.’ This review is intended to
refresh our knowledge of this enigmatic cell, discuss new
advances in the field, and challenge clinicians and investiga-
tors to invest in clarifying the precise biology and function of
PECs in health and disease.
DISEASES OF PECs
To date, we associate many glomerular diseases with primary
injury to a specific cell type. For example, thrombotic
microangiopathies are associated with injury to glomerular
endothelial cells; mesangial proliferative glomerulopathies
such as IgA nephropathy is due to mesangial cell injury; and
many forms of nephrotic syndromes such as focal segmental
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glomerulosclerosis (FSGS), minimal change disease, and
membranous nephropathy are due to injury of podocytes.
What about PECs? To date, it is the authors’ view that there is
no conclusive evidence to support a primary form of injury to
PECs. We know, however, that PECs are very reactive in many
forms of glomerular diseases and even undergo robust
proliferation in diseases of the glomerular basement membrane
(GBM) (e.g., anti-GBM disease) and diseases of the endothelial
cells (e.g., anti-neutrophil cytoplasmic antibody (ANCA) and
pauci-immune glomerulonephritis). Many have suggested that
PECs proliferate in collapsing forms of FSGS. Yet, in all these
diseases, it appears that PECs are responding secondarily to
injury elsewhere (GBM, endothelial cells, podocytes). This
observation does not minimize their importance by any means,
but rather should be viewed as a challenge to unravel the
mysteries of this cell, in health and disease.
PEC DEVELOPMENT AND GLOMERULOGENESIS
In order to fully understand the role of PECs in health and
disease, we must first define its origin. PECs share a common
lineage with other epithelial cells of the kidney. The definitive
adult kidney of higher vertebrates develops through a series
of inductive interactions between the ureteric bud and the
surrounding metanephric mesenchyme. The later develops
into the renal vesicle, which forms glomeruli and tubules.
The presumptive glomerulus passes through distinct and
sequential developmental stages called the comma, S-shape,
capillary loop, and mature stages.1 The two epithelial cells of
the glomerulus, PECs and visceral epithelial cells (podocytes),
share a common lineage until the S-shaped stage of
glomerulogenesis. Between the S-shaped body and capillary
loop stages, each cell begins to express distinct genes, used as
‘cell-specific markers.’ For example, Wilm’s tumor suppressor
protein 1 (WT-1) expression is no longer detected in PECs,
whereas podocytes maintain WT-1 and gain vimentin
expression. In mice, PECs express CD10 in the capillary
loop stage of development.2 Thus, mature PECs and podo-
cytes express distinctive cell-type markers that can be used to
distinguish them under normal conditions.
Regulation of PEC development
Mounting evidence suggests certain growth factors have a
critical role in PEC development. Crim1, a transmembrane
cysteine-rich repeat containing protein that tethers growth
factors to the cell surface, is expressed in PECs during kidney
development. Crim1 null mice are lethal with glomerular
capillary loop dilation.3 Drummond et al.4 identified
fibroblast growth factor 2 (FGF2) as a potential growth
factor important in kidney development, which is expressed
in nephron precursors and differentiating PECs. Platelet-
derived growth factor D (PDGF-D) is expressed in the
comma and S-shaped stages of glomerular development
and by podocytes in later stages. However, the receptor
for PDGF-D localizes to PECs. The proximity between
PDGF-D expression by podocytes and its receptor on PECs
suggests a possible paracrine role for PDGF-D on PEC
development.5
Evidence suggests a role for protein kinase C beta II
signaling,6 vitamin D,7 cytokeratins,7 desmosomal antigens,8
and vimentin9 in PEC development. These studies provide
important information in our understanding of PEC
development, but further studies of these and other potential
regulators are necessary to gain a more complete under-
standing of PEC development and differentiation.
NORMAL STRUCTURE AND HISTOLOGICAL CHARACTERISTICS
OF PECs
Normal structure of mature PECs
Although the border surrounding the urinary space of the
glomerulus is commonly referred to as Bowman’s capsule, it
is more accurate to refer to this structure as Bowman’s
basement membrane (BBM) lined by a monolayer of PECs,
which resemble squamous epithelial cells, with a small cell
body size ranging in thickness from 0.1 to 0.3micro m,
increasing to 2.0–3.5micro m at the nucleus.10 Scanning
electron microscopic studies show that PEC surfaces are lined
by the microvilli and cilia.11 Interestingly, there is variation in
the presence of microvilli and cilia, as not all PECs have
microvilli; the number of cilia range from 0 to 2 per cell
(Figure 2).11 The number of PECs in a normal rat glomerulus
is estimated to comprise 14.8% of all glomerular cells.12
Despite their thin cell bodies, PECs form junctions
between adjacent cells, comprising a very complicated and
delicate structure, described as ‘labyrinth-like.’ Transmission
electron microscopic studies show tight junctions near the
apical surface of PECs (Figure 3). The proteins expressed in
PEC tight junctions are described below.
Interface between PECs and other glomerular cells
At the urinary pole of the glomerulus, PECs form junctions
with proximal tubular cells (Figure 4). At the vascular pole of
the glomerulus, PECs transition with podocytes. Indeed,
Figure 1 | The highlighted areas show the Bowman’s
basement membrane lined by a monolayer of PECs,
surrounding the urinary space. This is typically referred to as
Bowman’s capsule. PEC, parietal epithelial cells.
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Gibson et al.13 noted that podocytes in this region are often
located on BBM in human glomeruli. Moreover, podocytes
on BBM form foot processes and slit diaphragms (Figure 5),
just as they do when situated on the GBM. Accordingly, the
authors named this subset of cells ‘parietal podocytes,’
(pPods) and now are often referred to as pPod. They are
present in 63% of glomeruli in normal human kidneys by
scanning electron microscopy. Furthermore, pPods form a
bridge between BBM and the GBM (Figure 5).13 Although
pPods were described ultrastructurally by Gibson, Bariety
et al.14 recently noted that pPods express several proteins
considered specific to podocytes (discussed below). Follow-
ing these reports, the concept of the pPod has now become
more widely accepted, although their origin and function has
yet to be determined.
PECs and pPods at not the only cells lining BBM. Another
distinct glomerular cell located at the vascular pole was
reported by Ryan et al.,15 called the peripolar cell (Figure 6).
Peripolar cells are characterized by their localization at the
vascular pole on BBM, between podocytes and PECs. Their
cytoplasm is periodic acid Schiff-positive and contains large
electron-dense granules (Figure 7). Newborn lambs have a
prominent number of peripolar cells with a large number of
granules, containing albumin, immunoglobulin, neuron-
specific enolase, and transthyretin.16,17 Peripolar cell cyto-
plasm also contains renin, suggesting, although not proving,
that peripolar cells may be involved in the control of blood
flow into the glomerulus.
BBM
A discussion of PECs cannot be complete without acknowl-
edging BBM, given that PECs are adherent to this membrane.
BBM is an especially thick basement membrane that differs in
composition from the GBM with which it is contiguous.
Podocyte
US
PEC
500 nm
BBM
Figure 3 | Transmission electron microscopic image showing
the interface between adjacent parietal epithelial cells (PECs)
and a tight junction near the top (indicated by the arrow).
Figure 4 | Scanning electron microscopic image of the
interface between the parietal epithelial cell (PEC) and the
proximal tubule at the urinary pole of the glomerulus.
Reprinted with permission from Lee et al.118
Figure 2 | Scanning electron microscopic image of parietal
epithelial cells (PECs) lining Bowman’s basement membrane.
The cell nucleus is indicated by an arrow, cilia are indicated by the
black arrowhead, and microvilli are indicated by the white
arrowhead. Reprinted with permission from Arakawa and
Tokunaga.11
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Figure 5 |Transmission electron microscopic image of the
vascular pole of the glomerulus showing a bridging parietal
podocyte (BPP) and foot processes formed on both the
glomerular basement membrane (GBM) and Bowman’s
basement membrane (BBM) sides of the parietal podocyte.
Bridging parietal podocytes often bridge the GBM and the BBM,
as shown here. Reprinted with permission from Gibson et al.13
A, arteriole of vascular pole; C, pericapsular capillary;
CL, capillary loop.
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BBM is presumably synthesized exclusively by PECs,
although this has not yet been definitively proven. Like all
basement membranes, BBM contains laminin, collagen IV,
nidogen, and heparan sulfate proteoglycans. Data in the
literature indicate that specific isoforms of some of these
matrix protein classes are present.
The major laminins deposited into BBM include both
laminin-111 (a1b1g1) and laminin-511 (a5b1g1).18,19 Re-
garding collagen IV, the major networks appear to be collagen
a1,a2(IV) and collagen a5,a6(IV), although the a3(IV) chain
has also been observed.20,21 The presence of a5 and a6(IV)
distinguishes BBM from the GBM, which lacks a6(IV).
Despite the prominence of COL4A5, which is mutated or
missing in most cases of Alport syndrome, there are no
reported BBM-specific defects associated with this disease.
Both nidogens-1 and -2 are present in BBM and likely
contribute to its stability by binding both laminin and
collagen IV.22 Regarding heparan sulfate proteoglycans in
BBM, both perlecan and collagen XVIII are present,23
although their functions have not yet been identified. Clearly,
further study of the BBM is needed.
PROTEINS EXPRESSED BY PECs
Recent studies have shown that many renal cell types express
unique genes, which serve not only as a ‘marker’ for
identification specificity on a biopsy but likely also serve
cell-type-specific functions. Several excellent reviews discuss
podocyte-specific proteins in health and disease. Several
proteins expressed by PECs have also recently been described,
and these are listed in Table 1. We have listed PEC proteins
based on their potential functional classification:
Junctional proteins
Parietal epithelial cells contain junctional structures, includ-
ing several tight junction proteins and cadherins. Claudins
form a major component of tight junctions. Of the claudins
expressed in mouse kidneys, claudin-1, -2 and -3 are
expressed in PECs.24–26
Zonula occludens-1 (ZO-1) expression has been shown in
PECs by immunofluorescent staining and immunogold
electron microscopy.27 We recently confirmed the expression
of ZO-1 and occludin in PECs in mouse, rat, and humans.28
The expression pattern of these tight junction proteins was
consistent with junctional structures. At least two cadherins
are expressed in PECs: K-cadherin (Cdh6)29 and kidney
specific-cadherin (Cdh16).30
Transcription factors
Igarashi30 reported that the transcription factor HNF1b,
which regulates kidney specific-cadherin, is expressed in
PECs. Another transcription factor from the paired box
family, PAX2 is exclusively expressed within the glomerulus
in PECs.31 PAX2 is involved in regulating genes governing
proliferation, cell growth, and survival, and interestingly has
reciprocal expression levels with the transcription factor WT-
1 in podocytes. We have recently shown that within the
glomerulus, another member of the paired box gene family,
PAX8 was also exclusively expressed in PECs.28
Endopeptidases and ubiquitin-related proteins
CD10, also known as CALLA or neutral endopeptidase, has
been used to detect PECs in an experimental model in
mice.32 Interestingly, CD10 is present in the PECs in mice
and rats, whereas CD10 is positive only in the podocyte in
humans and rabbits.31,33
Protein gene product 9.5 (PGP9.5), a ubiquitin-related
protein, was originally discovered as a neuron-specific
protein,34 and was later also detected in rat PECs.35 PGP9.5
levels was detected in mouse26 and human PECs.36
Antioxidants
The antioxidant ceruloplasmin increases in rat PECs in an
aging-dependent manner.37
EA
MD
AA
Figure 6 | Schematic of the arrangement of a peripolar cell at
the vascular pole of the glomerulus. The peripolar cell sits
between the parietal epithelial cells (PECs) and the podocyte, as
indicated by the arrow. AA, afferent arteriole; EA, efferent
arteriole; MD, macula densa. Reprinted with permission from
Gardiner et al.17
er
m
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Figure 7 | Transmission electron microscopic image of a
peripolar cell with periodic acid Schiff–positive electron-dense
granules contained within the cytoplasm. Reprinted with
permission of Gardiner et al.17 er, endoplasmic reticulum;
m, mitochondria.
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Intermediate filament proteins
Cytokeratin, desmin, and vimentin are all intermediate
filament proteins. The cytokeratin family has 54 protein
members in humans.38 Although PECs have been shown to
express cytokeratin using a mixture of monoclonal antibody
C2562, the specific members of the 54 cytokeratins have not
yet been determined. To date, only cytokeratin 8 (KRT8) has
been shown in PECs.31 Desmin and vimentin are expressed in
podocytes, but not in PECs.39
As mentioned earlier, the expression of typical podo-
cyte proteins such as glomerular epithelial protein-1,
podocalyxin, nephrin, vascular endothelial growth factor,
a-actinin, and synaptopodin have been described in
pPods.14 Interestingly, certain proteins are expressed in
pPods but not in podocytes. For example, PAX2 is expres-
sed in pPods and PECs but not in podocytes. Some pPods
did not express CKIp57, whereas podocytes broadly
expressed CKIp57. Also noteworthy was one study that
noted 74% of the cells on Bowman’s capsule were positive
for WT-1.14
NORMAL FUNCTION OF PEC
Having defined the origin, structure, and proteins unique to
the PECs, we now ask what is the function of PECs? In
contrast to other kidney cell types, there are relatively few
published studies on the functions and biological roles of
PECs in either health or disease. Therefore, the function(s) of
PECs remain fairly speculative at this time. Because PECs are
epithelial cells, many authors have simply taken ‘editorial
license’ to list PEC functions as typical of other epithelial cells
to include secretion, absorption, protection, transcellular
transport, sensation detection, cleaning (mucous), reducing
friction, and selective permeability. However, the authors of
this review caution the reader that although plausible, there
is no proof of these functions at this time. Described below is
the best evidenced-based information on PEC function.
Permeability barrier
In 1971, Webber and Blackbourn40 tested the concept that
PECs reduce permeability. Transmission electron microscopy
showed PECs have both simple and elaborately folded
Table 1 | Proteins expressed in PECs, podo, and pPod
Category Protein PEC Podocyte pPod Reference
Transcription factor (PEC) PAX2 +++  + Bariety et al.14 (h)
PAX8 +++  + Ohse et al.28
HNF1b +  NA Igarashi30
Tight junction Claudin-1 +  + Kiuchi-Saishin et al.24 and Ohse et al.26
Claudin-2 +  NA Kiuchi-Saishin et al.24 and Ohse et al.26
Claudin-3 + + NA Done et al.25
Occludin +  NA Ohse et al.28
ZO-1 + + NA Schnabel et al.27 and Ohse et al.28
Other junction K-cadherin +  NA Cho et al.29
KSP-cadherin +  NA Igarashi30
Enzyme PGP9.5 +  NA Shirato et al.35 (rt)
Diomedi-Camassei et al.36 (h)
Ohse et al.26 (m)
CD10 + + (human) NA Smeets et al.32 (m)
Dijkman et al.31 and Debiec et al.33 (h, rab)
Antioxidant Ceruloplasmin +  NA Wiggins et al.37 (rt)
Intermediate filament Cytokeratin (mAb C2562) +   Bariety et al.14 (h)
Cytokeratin 8 +  NA Dijkman et al.31
Desmin  + NA Stamenkovic et al.39
Vimentin  + NA Stamenkovic et al.39
Glycoprotein Podocalyxin  + + Bariety et al.14 (h)
Transcription factor (podocyte) WT-1  + + Bariety et al.14 (h)
Slit diaphragm Nephrin  + + Bariety et al.14 (h)
Podocin  + + Bariety et al.14 (h)
Actin-associated a-ACTN4  + + Bariety et al.14 (h)
Synaptopodin  + + Bariety et al.14 (h)
Tyrosine phosphatase GLEPP-1  + + Bariety et al.14 (h)
Cell cycle CKIp57  + ± Bariety et al.14 (h)
Growth factor VEGF  + + Bariety et al.14 (h)
ACTN-4, actinin; GLEPP, glomerular epithelial protein; h, human; HNF1b, hepatocyte nuclear factor; KSP, kidney specific; m, mouse; mAb, monoclonal antibody; NA, not applicable;
PAX, paired box gene 2; PEC, parietal epithelial cell; PGP9.5, protein gene product 9.5; Ppod, parietal podocyte; rt, rat; VEGF, vascular endothelial growth factor; WT-1, Wilm’s tumor
suppressor protein 1; ZO-1, zonula occludens-1.
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junctions containing desmosomes, intermediate junctions,
and tight junctions. PECs were semi-permeable to 40 kDa
horseradish peroxidase through intercellular clefts. Horse-
radish peroxidase was also detected inside pinocytic vesicles
within the PEC cytoplasm. These observations were not
pursued further, but suggest that PECs might function as a
selective permeability barrier and for transcellular transport.
Our group has recently extended the notion that PECs
function as a permeability barrier to urinary filtrate.28 We
showed that although the tight junctional proteins claudin 1,
ZO-1, and occludin are normally expressed in PECs, the inten-
sity of immunostaining was strikingly reduced in experimental
anti-GBM disease. Moreover, permeability measured in vivo
with two tracers (Texas red-labeled dextran (3 kDa) and Texas
red-labeled ovalbumin (40 kDa)) showed increased permeabil-
ity across the BBM-PEC structure in experimental anti-GBM
disease. Indeed, following the induction of disease, tracers were
distributed within the cytoplasm of podocytes and PECs,
between the multiple layers of PECs in crescents, in the space
between PECs and BBM, and in the periglomerular space.
These studies showed that PECs may serve as a final
permeability barrier to the urinary filtrate (Figure 8).
Albumin uptake
Although podocytes have an integral role in the glomerular
filtration barrier, injury to the GBM leads to the passage of
albumin and other plasma proteins across this barrier.
Yoshida et al.41 showed both in vivo and in vitro, that
albumin overload results in albumin uptake by podocytes
and that this precedes podocyte injury. Similarly, on the basis
of our unpublished data, we hypothesize that PECs take up
albumin in states of albumin overload such as nephrotic
diseases, likely by endocytosis. Our data suggest that
increased intracellular albumin concentrations leads to PEC
injury. The mechanisms involved in albumin uptake and
whether this eventually leads to PEC apoptosis, proliferation,
or transdifferentiation remains to be delineated.
Contractility
As PECs contain filaments in the basal membrane region,
Webber and Wong tested the hypothesis that PECs perform a
contractile function. Histamine, acetylcholine, or adrenaline
was injected into rats or were applied to 5mm kidney tissue
sections from rats. In contrast to the smooth basal cell
membranes of PECs in control conditions, exposure to
adrenaline induced moderate folding. However, the authors
concluded that although adrenaline induced conformational
changes, the contractile mechanism did not appear to involve
the bundles of basal filaments on the basal membrane aspect
of the PEC and that these filaments appear to have primarily
a structural role.42
Mechanosensation
Parietal epithelial cells possess primary cilia,11 which in other
mammalian cells such as renal tubular epithelial cells, serve as
important chemical and mechanical sensors. Studies in renal
tubular cells have shown that primary cilia in these cells are
responsible for a flow-mediated increase in intracellular
calcium that effects gene expression (reviewed in Yoder43).
We speculate that because primary cilia in PECs are
constantly exposed to flow from the glomerular filtrate,
PECs may serve a mechano-sensing function through its cilia.
TOOLS AND MODELS TO STUDY PECs
Having discussed which glomerular diseases are accompanied
by PEC injury, and having reviewed the normal development,
structure, and function of PECs, we will now discuss model
systems in which investigators can better understand and
define the biological role of PECs in health and disease, and
the mechanisms and events that governs these.
Immortalized PECs in culture
Cell culture model systems are used to complement studies in
humans and animals to further explore detailed mechanistic
insights in vitro that simply cannot be performed in vivo.
Several investigators have attempted to develop a PEC in vitro
model. Harper et al.44 established a homogeneous epithelial
cell primary culture derived from rat glomeruli characterized
by polygonal shape, numerous microvilli, and occasional
cilia. They simply called these cells ‘epithelial cells,’ but did
not discern if they were parietal or visceral epithelial
Protein
Podocyte
GEN GBM
PEC
BBM
Tight junction
Figure 8 | Schematic demonstrating the primary and
secondary barriers to proteinuria in the glomerulus. The
endothelium, GBM, and podocyte form the primary barrier to
protein. The parietal epithelial cells (PECs) with their tight
junctions form a secondary barrier to protein and prevent urinary
filtrate from escaping into the periglomerular and
tubulointerstitial areas. BBM, Bowman’s basement membrane;
GBM, glomerular basement membrane; GEN, glomerular
endothelial cell.
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glomerular cells. Two subsequent groups investigated the
characteristics of these primary cultures by showing the
expression profile of several proteins that are differently
expressed in PECs and podocytes, and concluded that these
cells were indeed PECs and not podocytes.45,46
Yaoita et al.47 generated polygonal cells, with cilia in
outgrowths from encapsulated rat glomeruli. They investi-
gated the difference in the morphology in cellular outgrowths
from encapsulated versus decapsulated glomeruli. They
assumed these cells were derived from PECs.
Because of the lack of a robust and well-defined PEC
culture model, we recently used transgenic mice with a SV40
temperature-sensitive large T antigen (tsA58 TAg) under the
control of major histocompatibility complex class I promo-
ter,48 similar to what has been used for podocyte cultures.
The rationale for this approach is that cells derived from
these mice express the immortalizing oncogene tsA58 TAg
when exposed to interferon and lower temperature. Mundel
et al.49 exploited this opportunity to grow podocytes in
culture with characteristics of their in vivo counterparts. More
recently, this ‘model system’ has been utilized to isolate other
glomerular cell types.26,50–52 Figure 9 shows how cultured
PECs were generated from tsA58 TAg transgenic mice using
standard differential sieving techniques and dilu-
tion cloning. It is technically critical to obtain capsulated glo-
meruli, because these contain both BBM and PECs. Capsu-
lated glomeruli were seeded onto collagen-coated plates at
very low density. Growth permissive conditions, the presence
of interferon and low temperature (33 1C), promote out-
growth of cells from adherent glomeruli. Several colonies con-
taining compact cell bodies were then isolated with cloning
cylinders. Single cell colonies were then isolated by dilution
cloning. PEC characterization was confirmed by immu-
nocytochemistry and western blot analysis, with positive signals
to claudin-1, -2, and PGP9.5 and negative signals to nephrin
and synaptopodin, characteristic of mouse PECs in vivo.
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(10% of total)°
Decapsulated
glomeruli
(90% of total)°
Selectively clone
capsulated glomeruli
and outgrowing cells
Expand cells from capsulated
glomeruli in 24-well plates
coated with type 1 collagen
Transfer to type 1
collagen-coated plates
33°
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g-I
FN
37
°
 C
ϕ180 mm
ϕ107 mm
ϕ75 mm
Harvest cortexH-2Kb tsA58 Tg mouse
Si
ev
in
g
Subclone putative PECs
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Differentiated
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Figure 9 | Schematic of the procedure for isolating immortalized mouse parietal epithelial cells. Capsulated glomeruli from H-2Kb
tsA58 tg mice were selectively isolated, and outgrowths were then subcloned to establish parietal epithelial cells (PECs) in culture that have
features of PECs in vivo. Reprinted with permission from Ohse et al.26
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Experimental animal models of PEC disease
To date, the best and perhaps only characterized human
disease involving PECs is crescentic glomerulonephritis
(GN). The clinical and histological features of this glomerular
disease are beyond the scope of this review. Several rodent
models have been developed to recapitulate these events in
order to better define the mechanisms and potential therapies
of disease (see Table 2).
Experimental autoimmune glomerulonephritis and
nephrotoxic nephritis
Both experimental autoimmune glomerulonephritis (EAG)
and nephrotoxic nephritis (NTN) are models of Good-
pasture’s syndrome. EAG is induced by immunizing animals
with either GBM or the non-collagenous domain of the a3
chain of type IV collagen, which induces an autoimmune
response that targets the animals’ own kidneys.53 NTN, often
called the anti-GBM model or anti-GBM disease, is induced
by administration of heterologous antibodies produced in
rabbits or sheep to GBM, whole glomeruli, or even the renal
cortex. Both models can be difficult to induce in mice; the
Wistar–Kyoto (WKY) strain tends to give the best response
when rats are used.54,55 Although disease occurs more quickly
in NTN than in EAG, progression is similar.
ANCA models
Models of pauci-immune necrotizing crescentic GN are often
associated with circulating anti-neutrophil cytoplasmic anti-
body (reviewed in detail by Falk and Jennette56) Four ANCA
models are available with features analogous to disease in
humans. Neumann et al.57 used an inbred mouse strain, the
spontaneous crescentic GN forming/Kinjoh (SCG/Kj) mouse.
SCG/Kj mice show neutrophilic perinuclear ANCA as early as
6 weeks of age and develop fibrocellular crescents in 57% of
glomeruli by 20 weeks of age.
Little and colleagues58,59 used immunizations with human
myeloperoxidase (MPO). Brown Norway, Wistar Furth,
Sprague–Dawley and WKY rats were all tested, but only
WKY rats developed crescentic GN. Disease is highly variable
and focal. The major determining factors were the dose of
human MPO, as well as the addition of pertussis toxin and
the number of killed Mycobacterium tuberculosis in the
adjuvant. Overall, 10–14% of glomeruli contained crescents.
The mouse model was developed in C57BL/6 mice and
was a bit more complicated. Ten days after the administration
of human MPO, sheep anti-mouse GBM antibody was
administered. Using MPO/ mice as well as CD4þ T-cell
depletion, they determined that an interaction between
MPO-ANCA and neutrophils deposited the autoantigen
(MPO) within glomeruli. This led to the recruitment of
CD4þ T cells, which directed a delayed type hypersensitivity-
like lesion, resulting in crescentic GN.60
Xiao et al.61 used auto-antibodies specific for MPO
generated by immunizing MPO/ mice with mouse
MPO. Splenocytes as well as isolated anti-MPO IgG from
these mice were then injected into Rag2/ mice, which lack
functioning B and T lymphocytes. Isolated anti-MPO IgG
was also injected into C57BL/6J mice. Varying degrees of
pauci-immune glomerular necrosis and crescents were
induced in all three circumstances, although disease was
much milder in C57BL/6J mice.
A variation on this model was recently established by
Schreiber et al. The model was performed two ways, first an
active model was performed by immunization with mouse
MPO derived from WEHI3 cells before transplantation of
MPOþ /þ bone marrow cells into MPO/ mice. In addi-
tion, a passive model was induced by passive transfer of MPO
antibody after transplantation of MPOþ /þ bone marrow
cells into MPO/ mice. In both cases, necrotizing cre-
scentic GN was induced. The model highlighted that target-
ing bone marrow with anti-MPO was sufficient to cause anti-
MPO disease in the absence of MPO in any other cell type.62
In addition to these models, PEC injury and crescents
have been noted in several transgenic mouse lines (see
Table 3). Although the targets of injury in these mice
vary and PECs were not the direct target of injury, PEC injury
and crescents formation did occur in all of them. This
underscores the lack of understanding of how PECs are
injured.
PEC RESPONSE TO INJURY
The manner in which cells respond to injury in disease
determines the severity, clinical picture, and response to
therapy. Thus, it is critical to understand how PECs respond
when injured, and how they might possibly undergo repair in
Table 2 | Experimental models of PEC disease
Human disease Name of model Species Mechanism of disease induction
Crescentic GN53 Experimental autoimmune
glomerulonephritis
Rat Autoimmune response to a3 chain of type IV collagen (a3(IV)NC1)
Crescentic GN54,55 Nephrotoxic nephritis Rat and
mouse
Heterologous anti-GBM sheep antibody
RPGN/ANCA57 SCG/Kj mouse Mouse Spontaneous crescentic glomerulonephritis forming/Kinjoh (SCG/Kj) mouse
RPGN/ANCA58–60 Human MPO Rat and
mouse
Immunization with human myeloperoxidase (MPO)
RPGN/ANCA61 Anti-MPO model Mouse Injection of anti-MPO antibodies or splenocytes generated in MPO/ mice
RPGN/ANCA62 Modified anti-MPO model Mouse Injection of MPO or anti-MPO antibodies in MPO/ mice transplanted with
MPO+/+ bone marrow
ANCA, anti-neutrophil cytoplasmic antibody; GBM, glomerular basement membrane; GN, glomerulonephritis; MPO, myeloperoxidase; PEC, parietal epithelial cell; RPGN,
rapidly progressive glomerulonephritis.
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order to heal. Described below are the typical responses of
PECs to injury (Figure 10).
PEC proliferation
Despite a common epithelial cell lineage, PECs and
podocytes differ in their proliferative capacity upon matura-
tion. Analysis of proliferative markers during development
has shown that as late as the capillary loop stage, precursor
and mature PECs proliferate, whereas podocytes do not.2,9
Upon maturation, PECs maintain low levels of proliferation
under non-diseased conditions. Pabst and Sterzel63 showed
the turnover for PECs in non-disease Sprague–Dawley rats is
about 1% per day, equivalent to the turnover in glomerular
endothelial cells and mesangial cells. Podocyte turnover was
not detected in these studies. Similar results were detected in
normal human kidney biopsies.64 Proliferation is perhaps the
best known hallmark of PEC injury, especially in crescentic
GN. Cellular crescents form in the urinary space due to
proliferation of cells. Although the origin of cells comprising
crescents has long been an area of debate, studies show that
infiltrating leukocytes,65,66 proliferating podocytes,67 and
proliferating PECs make up crescents.67 Thus, PECs pro-
liferate in humans with pauci-immune GN68 and in multiple
models of collapsing glomerulopathy.31,69–72 Less well-
appreciated is the fact that PECs also proliferate in many
forms of injury not associated with crescentic GN. Oda
et al.73 showed PECs proliferation during the early phase
(days 1–30) of post-streptococcal GN in human biopsies.
Kihara et al. showed PEC proliferation in human primary
FSGS. They noted podocyte detachment and bare basement
membrane in the central areas of the glomerular tuft, and in
peripheral areas, these denuded areas were covered with new
basement membrane and epithelial cells. These areas were
characterized by desmosomes and intercellular junctional
complexes, suggesting that PECs may have a role in repair
after podocyte injury.74
Nagata et al. showed that the cellular lesions in FSGS co-
expressed proliferative markers (Ki-67 and cyclin A) and the
PEC marker cytokeratin, but were negative for podocyte
markers. Electron microscopic analysis showed that these
large proliferating cells were characterized by junctional
complexes, cilia, and attachment to Bowman’s capsule,
features of PECs.71 Dijkman et al.75 also showed in human
FSGS that proliferating cells did not express podocyte
markers but did express PEC markers. Smeets et al.32 showed
that after the initial podocyte injury in the Thy1.1 transgenic
mouse model of collapsing FSGS, there is marked epithelial
cell proliferation in cells expressing the PEC marker, CD10.
Potential mechanisms underlying PEC proliferation have
been studied. Clues might come from studies of cell-cycle
proteins. Cyclin-dependent kinase (cdk) inhibitors are
negative regulators of proliferation. Expression of the cdk
inhibitor proteins p21 and p57 were not detected in healthy
PECs, whereas p27 was expressed at low levels. This contrasts
with abundant levels of p27 and p57 in healthy podocytes. In
experimental and human forms of FSGS, PECs increase the
expression of the DNA synthesis marker, Ki-67, and cyclin A,
which are essential for DNA synthesis. These changes were
accompanied by decreased p27 levels, and an absence of p21
and p57.71,76 Suzuki et al.69 recently showed in a mouse
model of FSGS, PEC proliferation was in part regulated by
p21, where p21/ mice had more epithelial cell proliferation
not of podocyte lineage, suggesting p21 limits PEC
proliferation in this disease model.
Another potential regulator of PEC proliferation is
PGP9.5, mentioned earlier.36 It is expressed in presumptive
and mature PECs and in cellular crescents.35,77 Ubiquitin
pathways function to modulate cellular homeostasis through
Proliferation
Apoptosis
EMT
Permeability
Growth
factor
Injury
CTGF EGF
Normal PEC
Figure 10 |Proposed schematic of the various responses of
parietal epithelial cells (PECs) to injury, which can include
secretion of growth factors, increased permeability,
epithelial-to-mesenchymal transition (EMT), apoptosis,
or proliferation. CTGF, connective tissue growth factor;
EGF, endothelial growth factor.
Table 3 | Transgenic mice with PEC injury
Name of trangenic
mouse Mechanism of injury
Kd/kd collapsing
GN112,113
Spontaneous proliferative disease of renal
epithelium due to the gene encoding
prenyltransferase-like mitochondrial protein
(PLMP)
Tg26 HIV trangenic114 Express a replication-defective form of the
HIV-1 provirus lacking 3 kb of sequence
overlapping the gag and pol sequences
TGF transgenic115 Systemic overexpression of TGBb1
Podocyte-specific
Thy-1.1 transgenic32,116
Ectopic expression of the Thy1.1 antigen on
podocytes. Followed by the administration
of Thy1.1 monoclonal antibody
Podocyte-specific
Vhlh/ mice117
Deletion of Von Hippel–Lindau gene (Vhlh)
in the podocyte. Followed by preservation
of hypoxia-inducible factor (HIF) and de novo
expression of CXCR4
GN, glomerulonephritis; HIV, human immunodeficiency virus; PEC, parietal epithelial
cell; TGFb1, transforming growth factor-b1.
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selective protein degradation. The ubiquitin pathway inter-
acts with the cell cycle through degradation of target proteins
such as CKIp27, resulting in cellular proliferation.78–80 The
expression of PGP9.5 in PECs and in cellular crescents
suggests a potential role in modulating PEC proliferation.
Several studies have examined a role for growth factors in
mediating PEC proliferation. Connective tissue growth factor
(CTGF) expression is increased in crescents in several animal
models of PEC proliferation.46,81,82 FGF-1 and -2 increase in
PECs.83 Ng et al.84 showed that fibrocellular crescents
consisting of proliferating PECs express FGF-2 and trans-
forming growth factor-b (TGF-b). These findings were
substantiated in vitro by Kanemoto et al.,46 who used a rat
PEC cell line to test the effects of growth factors on PEC
proliferation. The results showed that FGF-2 stimulated PEC
proliferation. Although these initial studies suggest a role for
CTGF and FGF-2 in PEC proliferation, further studies are
required to validate these claims. A variety of other growth
factors with a potential role in PEC response to injury are
discussed in detail below.85–87
Apoptosis
A balance between proliferation and loss of PECs is critical to
maintaining the proper structure and function of the glomerulus.
Apoptosis (programmed cell death) of PECs and/or infiltrating
cells is often detected in crescentic lesions.88 Proliferation of both
PECs and podocytes (25% contribution) as well as infiltrating
inflammatory cells accounts for the cellular content of crescents67
(reviewed in Tipping and Timoshanko89). Studies suggest that
the transition from cellular crescents to fibrous crescents is
associated with (and may be due to) PEC apoptosis, which leads
to reduced cell numbers, which are replaced by scar tissue.90
We speculate that PEC apoptosis is a mechanism to normalize
cell number after crescent formation, similar to what happens in
mesangial cells in proliferative GN. The authors of this review
caution that definitive demonstration of PEC apoptosis such
as TdT-mediated dUTP-biotin nick-end labeling staining in
lineage tagged PECs or double staining for PEC markers and
TdT-mediated duTP-biotin NickEnd labeling is still lacking.
Reduced PEC number in response to glomerular injury is
not restricted to apoptosis, and may include detachment.
Achenbach et al.91 showed PECs in the urine of patients with
several proteinuric glomerular diseases (FSGS, membranous
nephropathy, and membranoproliferative GN), consistent with
PEC detachment during disease. Taken together, a decrease in
PEC numbers through apoptosis and/or detachment occurs
after injury. However, it is not clear if this is adaptive or
maladaptive.
Epithelial mesenchymal transition
Epithelial mesenchymal transition (EMT) describes a process
where epithelial cells lose their epithelial characteristics and
switch to a ‘mesenchymal phenotype.’92 Studies suggest that
EMT in the kidney underlies scarring.68,84,93–96 Recent evi-
dence supports EMT occurring in PECs. Ng et al.84 and
Fujigaki et al.96 showed increased a-smooth muscle actin in
PECs in two experimental models of crescentic GN models.
Shimizu et al.95 showed the involvement of integrin-linked
kinase (ILK) in the process of PEC EMT in vitro and in vivo.
We showed increased levels of SNAIL, which can cause loss of
claudins and occludin,97 in cultured PECs exposed to TGF-b
(unpublished data). Taken together, PECs undergo EMT.
Studies are needed to clarify the molecular mechanism of
EMT in PECs, and the consequences of this phenomenon.
Increased permeability
As mentioned earlier, the precise function(s) of PECs are still
poorly understood. Kriz’s98 group showed that both PECs
and BBM form a barrier against urine flow, and when the
PEC monolayer is stripped from the basement membrane,
urine flow is ‘misdirected.’ Tracer studies using lissamine
green and ferritin showed misdirected filtration into the
periglomerular area. On the basis of these results, they
proposed a model of misdirected filtration where loss of
PECs and adhesion of the glomerular tuft to the BBM
initiates leaking of urine into the periglomerular space by
forming a new urinary space that is continuous with the
space between the tubular epithelium and the tubular
basement membrane.
More recently, we hypothesized that PECs and BBM form
a secondary barrier to urinary filtrate due to their tight
junctional proteins (Figure 9).28 In contrast to Kriz’s findings,
our studies showed in an intact PEC monolayer, levels of
several tight junction proteins were reduced after injury,
leading to leaking into the periglomerular area.
Kriz’s group used two rat models of spontaneous FSGS,
whereas we used a mouse model of anti-GBM disease, and
different tracers and detection system were used. However,
both studies highlight the progressive injury that occurs
when the PEC permeability barrier to urinary filtrate is
disrupted.
PECs acquire many characteristics of podocytes after injury
Recently, several studies have reported the possibility that
PECs serve as local progenitor cells. Appel et al.99 performed
PEC tracing studies in transgenic mice that express inducible
lacZ mainly in PECs. LacZ was induced in PECs with
doxycycline on postnatal day 5, and the distribution of
labeled cells was examined at days 7, 12, and 21, weeks 6 and
12. Interestingly, labeled cells were found in the glomerular
tuft, and nephrin was co-expressed with lacZ in these cells.
The number of labeled cells in glomerular tuft increased over
time. The authors concluded that PECs were recruited into
glomerular tuft as podocyte progenitor cells during nephro-
genesis.
Romagnani’s group identified multi-potent progenitor
cells on Bowman’s capsule in the human kidney based on
hematopoietic stem cell marker expression. Isolated stem
cells showed an ability to differentiate into multiple
glomerular cell types, including podocytes under appropriate
cell culture conditions. Moreover, functionality was demon-
strated when injecting these cells into animals with
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adriamycin-induced nephropathy reduced proteinuria and
glomerular damage.100,101
Increase in growth factors
Several growth factors, such as CTGF, FGF-1 and FGF-2,
PDGF, and TGF-b, have a role in the PECs response to injury.
As discussed earlier, one response that PECs have to injury is
proliferation. CTGF, a pro-fibrotic factor was found to be
expressed in crescents in human GN.102 Subsequent studies
further examined the role of CTGF in the progression of
crescentic GN. In an experimental model of proliferative GN,
CTGF mRNA expression by PECs increased as early as day 1,
before any increase in fibroblasts.82 This early upregulation
suggests that CTGF may be involved in the physiological
response to the injury and perhaps affect other cells in a
paracrine manner. In a rat model of crescentic GN,
Kanemoto et al.46 showed that crescents exhibited expression
of CTGF mRNA in the absence of a macrophage marker,
suggesting that PECs synthesized CTGF and this participates
in scarring. In a study of human crescentic GN, Kanemoto
et al.103 showed CTGF expression by PECs in cellular
crescents that may be involved in extracellular matrix syn-
thesis. TGF-b1, a potent inducer of CTGF, and its receptor,
TGF-b receptor-1, co-localized with CTGF mRNA-positive
crescents.
Increased acidic FGF-1 was seen in PECs of patients with
chronic allograft nephropathy and the FGF receptor was also
seen in glomerular lesions.104 FGF-1 and its receptor was not
increased in various inflammatory renal diseases such as
lupus nephritis and acute interstitial nephritis, and acute
rejection superimposed on chronic allograft nephropathy.105
In the same family, FGF-2 mRNA and FGF-2 protein were
found to be expressed in human PECs in kidneys removed
for tumors, but the expression of its receptor, FGFR1, was
present in tubular cells but not in the glomerular tuft,
suggesting that FGF-2 may work through paracrine path-
ways.106 Further evidence supporting this was shown by
Sasaki et al., who administered FGF2 to rats with PAN
nephropathy. They saw podocyte injury and PEC prolifera-
tion. FGF2-neutralizing antibody decreased proliferation and
inhibited the formation of glomerular adhesions. In states of
injury, it has been shown that damaged podocytes releases
FGF2. This further suggests a paracrine effect of FGF2 on
PEC proliferation.107
Fujigaki et al. showed minimal expression of PDGF-B and
its receptor PDGFR in the PECs of normal rats. However, in
anti-GBM disease, there was early immunostaining for
PDGF-B in PECs and strong expression for PDGFR in the
PECs adjoining crescents, suggesting a role in crescent
formation. Although these investigators also looked at the
expression of TGF-b, appropriate antibodies for TGF-b were
not available. They did find the expression of TGF-b
receptors, TbRI and TbRII, in PECs and crescents in early
disease.108 Taneda et al. used another disease model, thymic
stromal lymphopoietin transgenic mice that developed mixed
cryoglobulinemia and a membranoproliferative GN pattern.
They found increased expression of PDGF-B chain and its
receptor, PDGFb-R, in PECs.109
Epidermal growth factor and its receptor (EGFR) are
involved in cell growth, proliferation, and differentiation. The
expression of EGFR was found more frequently in fibrocel-
lular crescents, chronic rejection, and FSGS, was human
kidneys, suggesting this pathway is also involved in extra-
cellular matrix production progression of kidney fibrosis.110
Integrin-linked kinase has been implicated in cell adhe-
sion, as well as extracellular matrix organization and EMT. In
rats with crescentic GN, ILK was expressed and activated in
cellular crescents, while the PEC marker PGP9.5 was
simultaneously expressed with a myofibroblast marker. This
suggests that increased expression and activity of ILK
contributes to EMT by PECs and subsequent formation of
cellular crescents.95
TGF-b also has a role in mediating EMT, as well as
regulating cell growth and differentiation and it has
complex relationships with various growth factors.82,95,107,109
To evaluate the role of TGF-b in renal dysfunction and
anti-GBM nephritis, TGF-b signal was blocked by a secreted
TGF-b receptor, which reduced crescent formation and
interstitial fibrosis, as well as a-smooth muscle actin,
a marker of smooth muscle cells and myofibroblasts.
As a-smooth muscle actin is detected in the PECs of rats
with anti-GBM nephritis, and TGF-b is associated with
transition of PECs to myofibroblasts,108 it can be surmised
that TGF-b blockade decreased EMT of PECs and decreased
crescent formation.111
The relationships between the growth factors discussed
and their effects on PECs are complex. Although it has been
shown that in states of injury, the expression of growth
factors by PECs increases, there is also evidence for a para-
crine effects where growth factors expressed by PECs may act
on neighboring cells and perhaps growth factors released by
neighboring cells affect PECs.82,106,107 This is a field ripe for
further studies to help elucidate these complex relationships.
SUMMARY AND CONCLUSIONS
Although much of the recent attention to studying
glomerular cells has been limited to mesangial cells,
endothelial cells, and podocytes, PECs have been least
studied. However, with newer tools to explore PECs, new
paradigms are being identified such as their ability to likely
transform into podocytes, and their role in limiting filtered
albumin from exiting the urinary space. These cells are not
inert as was previously believed, but likely are dynamic and
constantly responding to other cues within the glomerulus.
The cross-talk between PECs and other glomerular cells is
certainly a critical event that occurs, but is poorly under-
stood. Moreover, until such time as PEC-specific proteins are
identified, genetically engineered mice will be limited. The
authors recognize that although only few diseases are
primarily associated with PEC injury, PECs likely have a
large and unrecognized role in primary diseases of podocytes,
endothelial cells, and even mesangial cells. The field is wide
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open, and if recent history from podocytes is any gauge, we
anticipate a major increase in our understanding and
appreciation of PECs in normal glomerular health and
disease. The hope of course is that specific therapeutic targets
will be discovered so that the outcomes of patients with
glomerular disease will be improved substantially.
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